The latest figures from types of adhd in adults show that the inattentive, hyperactive‑impulsive and combined presentations together account for the full spectrum of adult ADHD cases. Employers can now benchmark reasonable adjustments against a clearer picture of how each subtype is distributed across the workforce.
Clinical categories across the NHS and NIMH
Both the UK’s National Health Service and the US National Institute of Mental Health organise adult ADHD around the same three symptom‑based groups. The NHS website lists an inattentive type and a hyperactive‑impulsive type as distinct diagnostic pathways, noting that many adults present with features of both.NHS does not publish prevalence numbers, but the categorical split is embedded in its assessment tools.
Across the Atlantic, the NIMH describes the core symptom domains of inattention, hyperactivity and impulsivity that underpin the clinical split used by clinicians worldwide.NIMH frames these domains as the basis for the three presentations that practitioners diagnose, even though the page does not label them as separate “presentations” per se.
Prevalence breakdown from ADHD Test
ADHD Test, a commercial provider of online screening tools, has quantified the share of each adult subtype for the first time in a public‑facing article. According to its data, the inattentive type makes up roughly 33% of adult cases, the hyperactive‑impulsive type about 7%, and the combined type the remaining 60%.
| Subtype | Share of adult ADHD cases |
|---|---|
| Inattentive | 33% |
| Hyperactive‑impulsive | 7% |
| Combined | 60% |
Source: ADHD Test
What the split means for employers
For senior managers and talent‑acquisition teams, the three‑type split translates into concrete accommodation strategies. Workers with the inattentive presentation often struggle with sustained focus, making flexible scheduling, task‑breaking tools and quiet workspaces valuable. The hyperactive‑impulsive minority may benefit from movement‑friendly policies, such as standing desks or brief activity breaks, to channel excess energy without disrupting colleagues.
The combined presentation, which dominates the prevalence picture, blends both sets of challenges. Employers therefore need a layered approach: clear, written expectations paired with the freedom to adjust work rhythms. The UK’s Equality Act already obliges organisations to make “reasonable adjustments” for neurodivergent staff, but the new prevalence data helps HR leaders prioritise resources where the greatest number of employees sit.
Market implications and next milestones
Beyond internal policy, the data point to a growing market for specialised assessment services and workplace‑training providers. Venture capital has already funded several digital‑health platforms that promise rapid, clinically‑validated ADHD screening for adults. With a clear 60% combined‑type majority, product developers can design modular solutions that address both inattentive and hyperactive‑impulsive symptoms in a single package.
Regulators are also watching. The NHS’s upcoming adult mental‑health pathway, outlined in its long‑term plan, is expected to embed the three‑type taxonomy into commissioning contracts. That would create a predictable demand for external diagnostic services, potentially opening a tender market for private providers.
From a strategic‑planning perspective, companies should track two milestones:
- Publication of the NHS’s formal adult ADHD assessment guidelines, slated for early 2027.
- Release of the next NIMH epidemiology report, which historically updates prevalence estimates every five years.
Both will either reinforce the current split or introduce refinements that could shift employer‑focused investment.
Where the evidence still gaps
While ADHD Test supplies the first publicly‑available prevalence percentages, the figures are based on self‑selected users of an online screening tool rather than a population‑wide epidemiological study. The NHS and NIMH pages confirm the categorical framework but do not provide comparable prevalence data, leaving a gap that academic researchers could fill.
Furthermore, the NIMH description stops short of labeling three distinct presentations, which means the terminology used by UK and US health authorities is not perfectly aligned. Employers should therefore treat the three‑type split as a practical heuristic rather than a rigid diagnostic rule.
Finally, the impact of each subtype on specific job functions remains under‑researched. Early case studies from the logistics sector suggest that inattentive employees excel in roles requiring deep analytical work when given uninterrupted time, whereas hyperactive‑impulsive staff thrive in fast‑paced, physically active environments. More sector‑wide data will be needed before firms can fine‑tune hiring algorithms.
Looking ahead
In the short term, the clearest action for business leaders is to audit existing neurodiversity policies against the three‑type framework and to pilot targeted adjustments for each group. In the medium term, monitoring the NHS guideline rollout and the next NIMH report will indicate whether the prevalence percentages hold steady or shift as diagnostic criteria evolve.
By treating the new prevalence data as a baseline rather than a final verdict, companies can stay agile, avoid over‑engineering accommodations, and position themselves as forward‑looking employers in a talent market that increasingly values neurodiversity.
For a broader view of how data‑driven adjustments are reshaping other industries, see the recent analysis of Volkswagen’s restructuring plan (Volkswagen’s €135 bn plan translates to €2.7 m per job cut –) and the financing trends behind Philips’ green bond (Philips prices €650M healthcare‑first EU green bond, 2.7× ov).